市場調查報告書

全球多模態成像市場:成長,趨勢,及預測

Multimodal Imaging Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 922024
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
價格
全球多模態成像市場:成長,趨勢,及預測 Multimodal Imaging Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 112 Pages
簡介

本報告提供全球多模態成像市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各技術·用途·終端用戶·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 慢性疾病患病率上升
    • 影像診斷法的技術進步
  • 市場阻礙因素
    • 多模態成像系統的高成本
    • 缺乏恰當的醫療保健基礎設施
  • 波特的五力分析

第5章 市場區隔

  • 各技術
    • PET / CT系統
    • SPECT / CT系統
    • PET / MR系統
    • 其他
  • 各用途
    • 腫瘤學
    • 眼科
    • 循環系統
    • 其他
  • 各終端用戶
    • 醫院
    • 診斷中心
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • GE Healthcare
    • Siemens Healthineers
    • Koninklijke Philips NV
    • Mediso Ltd.
    • Neusoft Medical Systems Co. Ltd
    • Spectrum Dynamics Medical
    • MILabs BV
    • Bruker Corporation

第7章 市場機會及今後趨勢

目錄
Product Code: 67531

Market Overview

The multimodal imaging market analyzed was expected to expand with a CAGR of nearly 5.2% during the forecast period. The major factors attributing to the growth of the multimodal imaging market are the growing incidence of chronic diseases like cancer, cardiac disorders, etc., and the increasing geriatric population globally. According to the United Nations, the number of people aged above 60 years is expected to double by the year 2050, rising from 962 million globally in 2017 to 2.1 billion in 2050. Furthermore the advancements in the diagnostic imaging, like using artificial intelligence in CT scans and growing health expenditure is a constructive sign for any medical device market including multimodal imaging systems, the adoption of advanced tools and equipment comprising multimodal imaging systems for diagnostics and research applications is growing in developing regions, which drive the market growth. However, the high cost of multimodal imaging systems and lack of appropriate healthcare infrastructure are the factors restraining the market.

Scope of the Report

As per the scope of the report, multimodal imaging systems describe to concurrent production of signals from more than one imaging technique. Multimodal imaging facilitates analyzing more than one molecule at a time so that cellular processes can be analyzed at the same time or the progression of these events can be monitored in present. This report is segmented by technique, by application, by end-user, and by geography.

Key Market Trends

PET/CT Systems Segment is Expected to Be the Fastest-Growing Segment

  • PET scan can be used to inspect the blood flow, oxygen intake, or the metabolism of organs and tissues. PET scans reveal problems at the cellular level, giving the best view of complex systemic diseases. It is majorly used to detect malignancies.
  • The PET/CT systems segment is expected to be the fastest-growing segment of the multimodal imaging techniques market. This can be credited to the increasing demand for early and accurate cancer diagnosis, expanding clinical evidence for the early diagnosis of Alzheimer's disease, increasing the use of PET/CT systems in cardiology and many other diseases.
  • The number of cancer cases has rised to 18.1 million new cases and 9.6 million deaths in 2018. As the prevalence of the cancer cases increases the market for PET/CT systems rises.
  • Furthermore, good reimbursement situations and technological improvements in the field of PET/CT are a few other reasons for the segment to lead the market.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall multimodal imaging market, throughout the forecast period. The market growth is due to factors such as the high prevalence of chronic diseases like cancer, cardiovascular diseases in the region and well-established insurance policies and the availability of advanced healthcare infrastructure are some of the key factors accountable for its large share in the market. In the North America region, the United States holds the largest market share due to factors such as an increasing number of geriatric populations, a large patient pool in the country, is anticipated to stimulate the demand in this region. According to the American Cancer Society, about 606,880 Americans are expected to die of cancer in 2019, which means 1,660 deaths per day. With the growing incidence of chronic diseases and due to the rapid adoption of technologically advanced imaging systems, the market flourishes in the region.

Competitive Landscape

The multimodal imaging market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Mediso Ltd., Neusoft Medical Systems Co., Ltd., Spectrum Dynamics Medical and others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Prevalence of Chronic Illness
    • 4.2.2 Technological Advancements in Diagnostic Imaging Modalities
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Multimodal Imaging Systems
    • 4.3.2 Shortage of Adequate Healthcare Infrastructure
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 PET/CT Systems
    • 5.1.2 SPECT/CT Systems
    • 5.1.3 PET/MR Systems
    • 5.1.4 Others
  • 5.2 By Application
    • 5.2.1 Oncology
    • 5.2.2 Ophthalmology
    • 5.2.3 Cardiology
    • 5.2.4 Others
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 GE Healthcare
    • 6.1.2 Siemens Healthineers
    • 6.1.3 Koninklijke Philips N.V.
    • 6.1.4 Mediso Ltd.
    • 6.1.5 Neusoft Medical Systems Co. Ltd
    • 6.1.6 Spectrum Dynamics Medical
    • 6.1.7 MILabs B.V.
    • 6.1.8 Bruker Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS